Thomas Vogl

Thomas Joseph Vogl (born 17 May 1958, Munich) is a German radiologist.

Vogl's work is in the fields of interventional oncology, vascular procedures, multidetector computed tomography (MDCT), magnetic resonance imaging (MRI), evaluation of contrast agent and MR-guided procedures.

Since 2005 Vogl is deputy medical director of the Institute for Diagnostic and Interventional Radiology at the University Hospital Frankfurt/Main.

[2] Vogl's experimental treatments, especially chemoembolization, have attracted many patients from abroad, pushing a Canadian health authority to emphasize that "there is no available evidence about the efficiency of chemoembolization to support its recommendation instead of systemic chemotherapy"[3] and Quebec Health Minister Gaétan Barrette to accuse him of "selling hope".

[4] Vogl admitted working closely with the Hallwang Clinic,[5] a controversial institution known for selling unproven and ineffective therapies alongside more conventional cancer treatments.